Related Experiment Video
Updated: Nov 14, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation
Ting Song1, Xiao Xin2, Peirong Cui1
1School of Nursing, Shanghai Jiaotong University, Shanghai, People's Republic of China.
Insights
Medication adherence in non-valvular atrial fibrillation (NVAF) patients is influenced by income, comorbidities, and self-efficacy. Higher income, fewer comorbidities, and greater self-efficacy correlate with better adherence to anticoagulants.
Area of Science:
- Cardiology
- Pharmacology
- Public Health
Background:
- Medication adherence is crucial for effective anticoagulation in non-valvular atrial fibrillation (NVAF).
- Poor adherence increases the risk of ischemic stroke and mortality in NVAF patients.
- Identifying factors influencing adherence is key to improving patient outcomes.
Purpose of the Study:
- To investigate medication adherence in patients with NVAF.
- To identify social-demographic, disease-related, and self-efficacy factors impacting adherence.
- To inform strategies for enhancing anticoagulation therapy effectiveness and safety.
Main Methods:
- A cohort of 170 NVAF patients on oral anticoagulation for at least 3 months was studied.
- The Morisky Medication Adherence Scale (MGL) was used; scores <4 indicated low adherence.
- Data collection occurred between June 2020 and September 2020 at a tertiary hospital.
Main Results:
- 29.4% of NVAF patients exhibited low medication adherence (MGL score <4).
- Factors associated with high adherence included higher monthly income, fewer comorbidities, and greater self-efficacy.
- Prescription of multiple drugs (OR: 3.51), high income (OR: 7.87), absence of other diseases (OR: 8.00), and high self-efficacy (OR: 1.42) were significant predictors.
Conclusions:
- Number of prescribed drugs, presence of comorbidities, monthly income, and self-efficacy significantly influence adherence to non-vitamin K antagonist oral anticoagulants (NOACs).
- These findings highlight the multifactorial nature of medication adherence in NVAF.
- Targeting these factors may improve patient adherence and reduce stroke risk.
Purpose:
Inadequate medication adherence among patients with non-valvular atrial fibrillation (NVAF) will directly affect the efficacy and safety of anticoagulation therapy, leading to a considerable increase in the risk of ischemic stroke and death. In this study, we aim to investigate medication adherence and identify the influencing factors, including social-demographic, disease-related information and self-efficacy.
Patients And Methods:
We recruited 170 patients with NVAF from a tertiary hospital atrial fibrillation outpatient clinics and cardiology ward from June 2020 to September 2020. Patients who had been taking oral anticoagulation medication for at least 3 months were included. And Morisky medication adherence scale (MGL) was used to assess the adherence to anticoagulants, which scores <4 were considered as low adherence.
Results:
Fifty (29.4%) NVAF patients had a MGL score<4. Monthly income, types of comorbidities, number of drugs, and self-efficacy were determinants of anticoagulation adherence. Binomial logistic regression showed that patients had been prescribed more durgs (OR: 3.51, p=0.002), had high monthly income (OR: 7.87, p=0.001), without other diseases (OR: 8.00, p=0.005), and with higher self-efficacy (OR: 1.42, p=0.001) showed high adherence.
Conclusion:
Number of drugs, types of comorbidities, monthly income, and self-efficacy were associated with the adherence of non-vitamin K antagonist oral anticoagulants (NOACs).
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Venous Thrombosis IV: Nursing Management
Factors affecting Blood pressure
Physiological Factors:

